Series E - CANbridge Pharmaceuticals
Investment Firm
Overview
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Announced Date
Dec 01, 2020
Closed on Date
Dec 02, 2020
Funding Type
Series E
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
8
Round Details and Background
CANbridge Pharmaceuticals raised $43000000 on 2020-12-01 in Series E
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 01, 2020 |  Series E - CANbridge Pharmaceuticals | 11 | - | 43.0M |
| May 23, 2017 | Series B - CANbridge Pharmaceuticals | 7 | - | 25.0M |
| Oct 27, 2015 | Series A - CANbridge Pharmaceuticals | 1 | - | 10.0M |
| Dec 02, 2014 | Series A - CANbridge Pharmaceuticals | 2 | - | 10.0M |